Artelo Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

LEASE (Tables)

LEASE (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of operating lease right-of use assets and lease information

		Three months ended
		March 31,
		2023				2022

Lease cost
Operating lease cost		$	11			$	7

Other information
Cash paid for operating cash flows from operating leases		$	11			$	8
Right-of-use assets obtained in exchange for new operating lease liability		$	-			$	-

Weighted-average remaining lease term — operating leases (year)			1.36				2.42
Weighted-average discount rate — operating leases			2.99	%			3.00	%

Schedule of operating lease liabilities future minimum lease payments

		Total

Nine months ending December 31, 2023			29
2024			24
Thereafter			-
			53
Less: Imputed interest			(1	)
Operating lease liabilities			52

Operating lease liability - current			37
Operating lease liability - non-current		$	15